Nanoparticles for Solving Diagnostic and Therapeutic Problems with COVID-19 (NANOVIR)

Back

Identifier313011AUW7
Funding schemeEuropean Structural and Investment Funds
Funding providerResearch Agency
Operational programmeOperational Programme Integrated Infrastructure
Principal investigator at UVLFVilček Štefan, prof. Ing., DrSc.
Project duration01.01.2021 – 30.06.2023
The NANOVIR project will contribute to increasing the participation of Slovak research institutions in international research projects aimed at combating the COVID-19 pandemic by supporting bilateral international scientific cooperation with the University of Aix-Marseille, France. The subject of the project's research is to solve diagnostic and therapeutic problems of COVID-19 with the use of magnetic nanoparticles. The project deals with the preparation, development and tuning of magnetic nanoparticle properties for more efficient isolation of viral RNA from the ballast of a complex clinical sample. The project is solved in cooperation with the partner research institutions of the applicant, UPJŠ and partners, UVMP and IEP SAS in the territory of the Košice Self-Governing Region (KSK) and will contribute to the creation of consortia for solving multidisciplinary problems between priority areas and to the development of existing university science parks and research centers at UPJŠ, UVMP and IEP SAS in relation to the priorities of RIS3 SK. The project envisages the expansion of research and innovation infrastructure and capacities for the development of excellent science and contribution to economic growth in the RIS3 specialization Population Health and Health Technologies.

Partners

  • Pavol Jozef Šafárik University in Košice (Project coordinator)
  • University of Veterinary Medicine and Pharmacy in Košice
  • Institute of Experimental Physics of the Slovak Academy of Sciences